842136-32-7

Basic information

• Product Name: Benzoic acid,5-broMo-2-(trifluoroMethyl)-,Methyl ester
• Synonyms: Benzoic acid,5-broMo-2-(trifluoroMethyl)-,Methyl ester;Methyl 5-broMo-2-(trifluoroMethyl)benzoate;Methyl 5-bromo-2-(trifluoromethyl)
• CAS NO: 842136-32-7
• Molecular Formula: C₉H₆BrF₃O₂
• Molecular Weight: 283.0419496
• Mol File: 842136-32-7.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 280.9±40.0 °C(Predicted)
• Appearance: /
• Density: 1.598±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Benzoic acid,5-broMo-2-(trifluoroMethyl)-,Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid,5-broMo-2-(trifluoroMethyl)-,Methyl ester(842136-32-7)
• EPA Substance Registry System: Benzoic acid,5-broMo-2-(trifluoroMethyl)-,Methyl ester(842136-32-7)

Safety Data

• Hazardous Substances Data: 842136-32-7(Hazardous Substances Data)

Usage

General Description

Benzoic acid, 5-bromo-2-(trifluoromethyl)-, methyl ester is a chemical compound with the molecular formula C9H6BrF3O2. It is a methyl ester derivative of benzoic acid that contains a bromine atom and a trifluoromethyl group. Benzoic acid,5-broMo-2-(trifluoroMethyl)-,Methyl ester is commonly used in organic synthesis and as a reagent in chemical reactions due to its unique chemical properties. It is also used as a building block in the production of pharmaceuticals and agrochemicals. Additionally, it can be used as an intermediate in the synthesis of various compounds for industrial applications.

Upstream product

• 21740-00-1 5-bromo-2-iodo-benzoic acid 
• 1717-59-5 2,2-difluoro-2-(fluorosulfonyl)acetic acid 
• 181765-86-6 5-bromo-2-iodo-benzoic acid methyl ester 
• 680-15-9 2,2-difluoro-2-(fluorosulfonyl)acetate 

Downstream Products

• 654-97-7 5-bromo-2-(trifluoromethyl)benzoic acid 

Relevant articles and documents

ETHYNYL COMPOUNDS, THEIR PREPARATION AND THEIR THERAPEUTIC USE FOR THE TREATMENT OF MALARIA

The present disclosure relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof wherein R1 means a fluorine atom or a perhalogeno linear alkyl radical containing 1, 2 or 3 carbon atoms; R2 means a chlorine atom, a linear alkyl radical containing 1, 2 or 3 carbon atoms or a perhalogeno linear alkyl radical containing 1, 2 or 3 carbon atoms, and R means a hydrogen atom or a radical of formula (la). The present disclosure also relates to processes for their preparation as well their therapeutic uses, in particular such as for use in the treatment of malaria.

PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH

Provided herein are Pyrazole Pyrazine Amine Compounds having the following structure:Formula (I). Wherein Q and R1-R3 are as defined herein, compositions comprising an effective amount of a Pyrazole Pyrazine Amine Compound and methods for treating or preventing inflammatory conditions, immunological conditions, cancer, neurodegenerative diseases, age-related diseases, cardiovascular diseases and metabolic conditions, or conditions treatable or preventable by inhibition of an IKK, or an IKK pathway, comprising administering an effective amount of a Pyrazole Pyrazine Amine Compound to a patient in need thereof.